NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION Title: Full Service Maintenance for two (2) multi-scan LFER PET/CT IN-VIVO Animal Imager instruments (i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98026Q00669. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition, including Brand Name. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed price purchase order on a non-competitive basis to Mediso USA LLC, 1530 Wilson Blvd STE 115, Arlington, VA, 22209-2447 to procure an annual full service maintenance contract for two (2) MultiScan LFER PET/CT IN-VIVO Animal Imager instruments located in Bethesda, MD. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2026-01 dated January 2026. (iv) The associated North American Industry Classification System (NAICS) code for this procurement is 811210 - Electronic and Precision Equipment Repair and Maintenance, and the small business size standard is $34M. This requirement is not set aside for small business. (v) Description of Requirement: The government requires the following brand name services: Instrument: Mediso MultiScan LFER 150 PET/CT Serial Number(s): LF000010-0008V1 and LF000010-0009V1 Service Plan: Mediso Preventative Maintenance and Service Agreement (brand name) Required by the National Institute of Allergy and Infectious Diseases (NIAID), Division of Intramural Research (DIR), Laboratory of Clinical Infectious Diseases (LCID), Tuberculosis Research Section (TRS). In NIAID clinical studies, we are using 18F-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) and high-resolution computed tomography (HR-CT) imaging to monitor response to chemotherapy in TB patients. The results have re-emphasized that TB in humans is a complex disease, usually presenting with a spectrum of lesions, both structurally and functionally, even within a single patient. The difficulty in the human studies is that we cannot make a direct physical correlation with the images we see by PET/CT and the changes in microbiologic and histopathologic outcome of the individual lesions and overall disease. By adding HR-CT and FDG-PET mo…